Literature DB >> 19384226

Lung injury after hemorrhage is age dependent: role of peroxisome proliferator-activated receptor gamma.

Basilia Zingarelli1, Paul W Hake, Michael O'Connor, Timothy J Burroughs, Hector R Wong, Joseph S Solomkin, Alex B Lentsch.   

Abstract

OBJECTIVE: The incidence of multiple organ failure in pediatric trauma victims is lower than in the adult population. However, the molecular mechanisms are not yet defined. We investigated whether the pathophysiologic characteristics of hemorrhage-induced lung injury may be age dependent and may be regulated by the peroxisome proliferator-activated receptor gamma (PPARgamma).
DESIGN: Prospective, laboratory investigation that used an established rodent model of hemorrhagic shock.
SETTING: University hospital laboratory.
SUBJECTS: Young (n = 67; 3-5 months old) and mature (n = 66; 11-13 months old) male rats.
INTERVENTIONS: Hemorrhagic shock was induced in young and mature rats by withdrawing blood to a mean arterial blood pressure of 50 mm Hg. After 3 hours, rats were rapidly resuscitated by infusing the shed blood and killed 3 hours thereafter.
MEASUREMENTS AND MAIN RESULTS: In young rats, lung injury was characterized by accumulation of red cells and neutrophils at the end of the resuscitation period; on Western blot analysis, lung expression of intercellular adhesion molecule-1 was increased. In contrast, the severity of lung injury was more pronounced in mature rats. Lung myeloperoxidase activity and expression of constitutive and inducible intercellular adhesion molecule-1 was significantly higher in mature rats compared with young rats. Mature rats also had higher plasma levels of cytokines and chemokines compared with young rats. This heightened inflammation was associated with higher degree of activation of nuclear factor-kappaB and down-regulation of PPARgamma and heat shock factor-1 in the lung of mature rats compared with young rats. Treatment with the PPARgamma ligand, the cyclopentenone prostaglandin 15-deoxy-Delta-prostaglandin J2, ameliorated lung injury in young, but not in mature animals.
CONCLUSIONS: Lung injury after severe hemorrhage is age dependent and may be secondary to a diverse regulation of PPARgamma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19384226      PMCID: PMC2765201          DOI: 10.1097/CCM.0b013e31819feb4d

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  52 in total

Review 1.  Adhesion molecules and hemorrhagic shock.

Authors:  G Martinez-Mier; L H Toledo-Pereyra; P A Ward
Journal:  J Trauma       Date:  2001-08

2.  Different IL-8 production by T and NK lymphocytes in elderly subjects.

Authors:  E Mariani; L Pulsatelli; A Meneghetti; P Dolzani; I Mazzetti; S Neri; G Ravaglia; P Forti; A Facchini
Journal:  Mech Ageing Dev       Date:  2001-09-15       Impact factor: 5.432

3.  Calpain inhibitor I reduces the activation of nuclear factor-kappaB and organ injury/dysfunction in hemorrhagic shock.

Authors:  M C McDonald; H Mota-Filipe; A Paul; S Cuzzocrea; M Abdelrahman; S Harwood; R Plevin; P K Chatterjee; M M Yaqoob; C Thiemermann
Journal:  FASEB J       Date:  2001-01       Impact factor: 5.191

4.  Downregulation of hepatic cytochrome P-450 isoforms and PPAR-gamma: their role in hepatic injury and proinflammatory responses in a double-hit model of hemorrhage and sepsis.

Authors:  Shinya Higuchi; Rongqian Wu; Mian Zhou; Thanjavur S Ravikumar; Ping Wang
Journal:  J Surg Res       Date:  2006-11-13       Impact factor: 2.192

Review 5.  Heat shock response and acute lung injury.

Authors:  Derek S Wheeler; Hector R Wong
Journal:  Free Radic Biol Med       Date:  2006-09-29       Impact factor: 7.376

6.  Mechanical ventilation and hemorrhagic shock-resuscitation interact to increase inflammatory cytokine release in rats.

Authors:  Lila Bouadma; Didier Dreyfuss; Jean-Damien Ricard; Geneviève Martet; Georges Saumon
Journal:  Crit Care Med       Date:  2007-11       Impact factor: 7.598

7.  Ciglitazone ameliorates lung inflammation by modulating the inhibitor kappaB protein kinase/nuclear factor-kappaB pathway after hemorrhagic shock.

Authors:  Ranjit S Chima; Paul W Hake; Giovanna Piraino; Prajakta Mangeshkar; Alvin Denenberg; Basilia Zingarelli
Journal:  Crit Care Med       Date:  2008-10       Impact factor: 7.598

Review 8.  Vascular smooth muscle and endothelial functions in aging.

Authors:  Oguzhan Yildiz
Journal:  Ann N Y Acad Sci       Date:  2007-04       Impact factor: 5.691

9.  Diverse cardioprotective signaling mechanisms of peroxisome proliferator-activated receptor-gamma ligands, 15-deoxy-Delta12,14-prostaglandin J2 and ciglitazone, in reperfusion injury: role of nuclear factor-kappaB, heat shock factor 1, and Akt.

Authors:  Basilia Zingarelli; Paul W Hake; Prajakta Mangeshkar; Michael O'Connor; Timothy J Burroughs; Giovanna Piraino; Alvin Denenberg; Hector R Wong
Journal:  Shock       Date:  2007-11       Impact factor: 3.454

10.  Proinsulin c-peptide exerts beneficial effects in endotoxic shock in mice.

Authors:  Michael G Vish; Prajakta Mangeshkar; Giovanna Piraino; Alvin Denenberg; Paul W Hake; Michael O'Connor; Basilia Zingarelli
Journal:  Crit Care Med       Date:  2007-05       Impact factor: 7.598

View more
  14 in total

1.  Age-Dependent Changes in AMPK Metabolic Pathways in the Lung in a Mouse Model of Hemorrhagic Shock.

Authors:  Lindsey R Klingbeil; Paul Kim; Giovanna Piraino; Michael O'Connor; Paul W Hake; Vivian Wolfe; Basilia Zingarelli
Journal:  Am J Respir Cell Mol Biol       Date:  2017-05       Impact factor: 6.914

Review 2.  Aging and injury: alterations in cellular energetics and organ function.

Authors:  Ninu Poulose; Raghavan Raju
Journal:  Aging Dis       Date:  2014-04-01       Impact factor: 6.745

3.  Resveratrol improves cardiac contractility following trauma-hemorrhage by modulating Sirt1.

Authors:  Bixi Jian; Shaolong Yang; Irshad H Chaudry; Raghavan Raju
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

Review 4.  The host response to sepsis and developmental impact.

Authors:  James Wynn; Timothy T Cornell; Hector R Wong; Thomas P Shanley; Derek S Wheeler
Journal:  Pediatrics       Date:  2010-04-26       Impact factor: 7.124

5.  Children with open tibial fractures show significantly lower infection rates than adults: clinical comparative study.

Authors:  Hui Chen; Shunyou Chen; Yi Shi; Yunan Lu; Bin Yu
Journal:  Int Orthop       Date:  2018-05-28       Impact factor: 3.075

6.  Influence of aging and hemorrhage injury on Sirt1 expression: possible role of myc-Sirt1 regulation in mitochondrial function.

Authors:  Bixi Jian; Shaolong Yang; Dongquan Chen; Irshad Chaudry; Raghavan Raju
Journal:  Biochim Biophys Acta       Date:  2011-04-30

7.  Metformin ameliorates gender-and age-dependent hemodynamic instability and myocardial injury in murine hemorrhagic shock.

Authors:  Dzmitry Matsiukevich; Giovanna Piraino; Patrick Lahni; Paul W Hake; Vivian Wolfe; Michael O'Connor; Jeanne James; Basilia Zingarelli
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-06-01       Impact factor: 5.187

8.  C-peptide, a novel inhibitor of lung inflammation following hemorrhagic shock.

Authors:  Ranjit S Chima; Timberly LaMontagne; Giovanna Piraino; Paul W Hake; Alvin Denenberg; Basilia Zingarelli
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2011-03-11       Impact factor: 5.464

9.  Liver apoptosis is age dependent and is reduced by activation of peroxisome proliferator-activated receptor-gamma in hemorrhagic shock.

Authors:  Basilia Zingarelli; Ranjit Chima; Michael O'Connor; Giovanna Piraino; Alvin Denenberg; Paul W Hake
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-11-19       Impact factor: 4.052

10.  Liver X receptor α activation with the synthetic ligand T0901317 reduces lung injury and inflammation after hemorrhage and resuscitation via inhibition of the nuclear factor κB pathway.

Authors:  Patrick D Solan; Giovanna Piraino; Paul W Hake; Alvin Denenberg; Michael O'Connor; Alex Lentsch; Basilia Zingarelli
Journal:  Shock       Date:  2011-04       Impact factor: 3.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.